Status:
COMPLETED
Evaluation of a Medication Disposal Program in Primary Care
Lead Sponsor:
Geisinger Clinic
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
Phase:
NA
Brief Summary
Evidence from recent trials primarily in the post-surgical patient population prescribed opioids for acute pain suggest patients more often properly dispose of unused opioids if instructed by a health...
Detailed Description
Prospective studies affirm that education and advice from providers to dispose of unused medications modestly improves medication disposal rates. Two recently published randomized controlled trials de...
Eligibility Criteria
Inclusion
- Any patient receiving a new opioid prescription in a face-to-face or telehealth encounter in select Community Medicine Service Line practices.
- "New opioid prescription" is defined as a prescription for an opioid medication, Categories II-V (not anti-tussive) to a patient who has no opioid on current medication profile and no opioid prescriptions in the previous 3 months.
- Preferred language, as documented in the electronic health record (EHR), is English.
- Providers in participating primary care practices who receive the Best Practice Alert (BPA) for eligible patients.
Exclusion
- none
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
1159 Patients enrolled
Trial Details
Trial ID
NCT04320004
Start Date
May 1 2020
End Date
June 30 2021
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger
Danville, Pennsylvania, United States, 17822